Cromolyn sodium or nedocromil in childhood asthma: Does it matter?

Clinical and Experimental Allergy

Volumn 30, Issue 2, 2000, Pages 164-171

  Konig P ^a   Grigg, C F ^b  

^a UNIVERSITY OF MISSOURI   (United States)

^b Private Consultancy   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE DIPROPIONATE; CROMOGLYCATE DISODIUM; NEDOCROMIL; THEOPHYLLINE;

ANTIINFLAMMATORY ACTIVITY; ASTHMA; CLINICAL PROTOCOL; COUGHING; DERMATITIS; DRUG EFFECT; DRUG EFFICACY; DRUG POTENCY; HUMAN; LEUKOCYTE ACTIVATION; MEDIATOR RELEASE; MYOSITIS; NAUSEA; PRIORITY JOURNAL; REVIEW; UNITED STATES; VOMITING;

ANTI-ASTHMATIC AGENTS; ASTHMA; BRONCHIAL HYPERREACTIVITY; BRONCHIAL PROVOCATION TESTS; CHILD; CROMOLYN SODIUM; HUMANS; NEDOCROMIL;

EID: 0033975631     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2222.2000.00689.x     Document Type: Review

References (64)

1. US Department of Health and Human Services. Expert Panel Report 2. Guidelines for the Diagnosis and Management of Asthma, NIH Publication no. 97-4051, April 1997.
2. National Institutes of Health, National Heart, Lung, and Blood Institute. Global Initiative for Asthma. Global strategy for asthma management and prevention NHLBI/WHO workshop report. Publication Number 95-3659, January 1995.
3. Foreman JC, Pearce FL. Cromolyn and nedocromil. In: Middleton E, Reed CE, Ellis EF, Adkinson NF, Yunginger JW, Busse WW, eds. Allergy: Principles and Practice. St Louis: Mosby; 1993:926-40.
4. Cox JS. Disodium cromoglycate: mode of action and its possible relevance to the clinical use of the drug. Br J Dis Chest 1971; 65:189-204.
5. Paterson NAM, Ahmad D, Lefcoe NM. Airways narrowing in exercise in normal subjects and the effect of disodium cromoglycate. Br J Dis Chest 1973; 67:197-207.
6. DeVries K, Gokemeijer JDM, Orie NGM, Peset R, Sluiter HJ. Response of the bronchial tree to allergic and non-allergic stimuli in patients with generalized obstructive lung diseases [In French]. Bull Int Union Tuberc 1976; 51:655-7.
7. Theoharides TC, Sieghart W, Greengard P, Douglas WW. Anti-allergic drug cromolyn may inhibit histamine secretion by regulating phosphorylation of a mast cell protein. Science 1980; 207:80-2.
8. Heinke S, Szucs G, Norris AA, Droogmans G, Nilius B. Inhibition of volume activated chloride currents in endothelial cells by chromones. Br J Pharmacol 1995; 115:1393-8.
9. Altounyan REC, Edwards AM, Lee TB, Cole M, McWilliam P. Beurteilung der wirksamkeit von Nedocromil - Natrium an hand klinisch-pharmakologischer Asthmamodelle. Atemwegs-Lungenkrankheiten 1986; 12:593-9.
10. König P, Hordvik NL, Kreutz C. The preventive effect and duration of action of nedocromil sodium and cromolyn sodium on exercise-induced asthma (EIA) in adults. J Allergy Clin Immunol 1987; 79:64-8.
11. de Benedictis FM, Tuteri G, Pazzelli P, Bertotto A, Bruni L, Vaccaro R. Cromolyn versus nedocromil: duration of action in exercise-induced asthma in children. J Allergy Clin Immunol 1995; 96:510-4.
12. Juniper EF, Kline PA, Morris MM, Hargreaves FE. Airway constriction by isocapnic hyperventilation of cold, dry air: comparison of magnitude and duration of protection by nedocromil sodium and sodium cromoglycate. Clin Allergy 1987; 17:523-8.
13. del Bufalo C, Fasano L, Patalano F, Gunella G. Inhibition of fog-induced bronchoconstriction by nedocromil sodium and sodium cromoglycate in intrinsic asthma: a double-blind, placebo-controlled study. Respiration 1989; 55:181-5.
14. Crimi N, Palermo F, Oliveri R, Cacopardo B, Vancheri C, Misretta A. Adenosine-induced bronchoconstriction: comparison between nedocromil sodium and sodium cromoglycate. Eur J Resp Dis 1986; 69 (Suppl. 147):258-62.
15. Dixon CMS, Barnes PJ. Bradykinin-induced bronchoconstriction: inhibition by nedocromil sodium and sodium cromoglycate. Br J Clin Pharmacol 1989; 27:831-6.
16. Dixon CMS, Ind PW. Inhaled sodium metabisulphite induced bronchoconstriction: inhibition by nedocromil sodium and sodium cromoglycate. Br J Clin Pharmacol 1990; 30:371-6.
17. Crimi E, Brusasco V, Brancatisano M, Losurdo E, Crimi P. Effect of nedocromil sodium on adenosine-and methacholine-induced bronchospasm in asthma. Clin Allergy 1987; 17:135-41.
18. Woenne R, Kattan M, Levison H. Sodium cromoglycate-induced changes in the dose response curve of inhaled methacholine and histamine in asthmatic children. Am Rev Respir Dis 1979; 119:927-32.
19. Hoag JE, McFadden ER Jr. Long-term effect of cromolyn sodium on nonspecific bronchial hyperresponsiveness: a review. Ann Allergy 1991; 66:53-63.
20. Sont JK, Bel EH, Dijkman JH, Sterk PJ. The long-term effect of nedocromil sodium on the maximal degree of airway narrowing to methacholine in atopic asthmatic subjects. Clin Exp Allergy 1992; 22:551-60.
21. Orefice U, Struzzo P, Dorigo R, Peratoner A. Long-term treatment with sodium cromoglycate, nedocromil sodium and beclomethasone dipropionate reduces bronchial hyperresponsiveness in asthmatic subjects. Respiration 1992; 59:97-101.
22. Morrison-Smith JM, Devey GF. Clinical trial of disodium cromoglycate in treatment of asthma in children. Br Med J 1968; 2:340-4.
23. Silverman M, Connolly NM, Balfour-Lynn L, Godfrey S. Long-term trial of disodium cromoglycate and isoprenaline in children with asthma. Br Med J 1972; 3:378-81.
24. König P. Conflicting viewpoints about treatment of asthma with cromolyn: a review of the literature. Ann Allergy 1979; 43:293-6.
25. Godfrey S, Balfour-Lynn L, König P. The place of cromolyn sodium in the long-term management of childhood asthma based on a three-to-five year follow-up. J Pediatr 1975; 87:465-73.
26. Dickson W, Cole M. Severe asthma in children: a 10 year follow-up. In: Pepys J, Edwards AM, eds. The Mast Cell: its Role in Health and Disease (Proc Int Symp Davos, Switzerland). London: Pitman Medical, 1979:343-52.
27. Businco L, Cantani A, Di Fazio A, Bernardini L. A double-blind, placebo-controlled study to assess the efficacy of nedocromil sodium in the management of childhood grass-pollen asthma. Clin Exp Allergy 1990; 20:683-8.
28. Armenio L, Baldini G, Bardare M et al. Double-blind placebo controlled study of nedocromil sodium in asthma. Arch Dis Child 1993; 68:193-7.
29. König P, Eigen H, Ellis E et al. The effect of nedocromil sodium on childhood asthma during the viral season. Am J Respir Crit Care Med 1995; 152:1879-86.
30. Edwards AM, Lyons J, Weinberg E et al. Early use of inhaled nedocromil sodium in children following an acute episode of asthma. Thorax 1999; 54:308-15.
31. Hambleton G, Weinberger M, Taylor J et al. Comparison of cromoglycate (cromolyn) and theophylline in controlling symptoms of chronic asthma. Lancet 1977; 1:381-5.
32. Cherniak RM, Wasserman SI, Ramsdell JW et al. A double-blind multicenter group comparative study of the efficacy and safety of nedocromil sodium in the management of asthma. Chest 1990; 97:1299-306.
33. Francis RS, McEnery G. Disodium cromoglycate compared with beclomethasone dipropionate in juvenile asthma. Clin Allergy 1984; 14:537-40.
34. Sarsfield JK, Sugden E. A comparative study of betamethasone valerate aerosol and sodium cromoglycate in children with severe asthma. Practitioner 1977; 218:128-32.
35. Hiller EJ, Milner AD. Betamethasone 17-valerate aerosol and disodium cromoglycate in severe childhood asthma. Br J Dis Chest 1975; 69:103-6.
36. Mitchell I, Patterson IC, Cameron SJ, Grant IWB. Treatment of childhood asthma with sodium cromoglycate and beclomethasone dipropionate aerosol singly and in combination. Br Med J 1976; 2:457-8.
37. Shapiro GG, Sharpe M, DeRouen TA et al. Cromolyn versus triamcinolone acetonide for youngsters with moderate asthma. J Allergy Clin Immunol 1991; 88:742-8.
38. Peterson W, Karup-Pederson F, Daugbjerg P et al. Sodium cromoglycate as a replacement for inhaled corticosteroids in mild-to-moderate childhood asthma. Allergy 1996; 51:870-5.
39. Ng SH, Dash CH, Savage SJ. Betamethasone valerate compared with sodium cromoglycate in asthmatic children. Postgrad Med J 1977; 53:315-20.
40. Price JF, Weller PH. Comparison of fluticasone propionate and sodium cromoglycate for the treatment of childhood asthma (an open parallel group study). Respir Med 1995; 89:363-8.
41. Capristo AF, Miraglia del Guidice M, Alfaro C, Maiello N. Corticosteroid-sparing effect of cromoglycate sodium and nedocromil. Med Inflammation 1994; 3:S25-S30.
42. König P, Shaffer J. The effect of drug therapy on long-term outcome of childhood asthma: a possible preview of the international guidelines. J Allergy Clin Immunol 1996; 98:1103-11.
43. Korhonen K, Korppi M, Remes ST, Reijonen TM, Remes K. Lung function in school aged asthmatic children: with inhaled cromoglycate, nedocromil and corticosteroid therapy. Eur Respir J 1999; 13:82-6.
44. Hakim EA, Hide D, Kuzemko J. Can nedocromil sodium substitute for sodium cromoglycate in children with asthma? Eur Respir J Supplement 1994; 18:139S.
45. Lal S, Dorow PD, Venho KK, Chatterjee SS. Nedocromil sodium is more effective than cromolyn sodium for the treatment of chronic reversible obstructive airway disease. Chest 1993; 104:438-47.
46. Schwartz HJ, Blumenthal M, Brady R et al. A comparative study of the clinical efficacy of nedocromil sodium and placebo. How does cromolyn sodium compare as an active control treatment? Chest 1996; 109:945-52.
47. Boldy DAR, Ayres JG. Nedocromil sodium and sodium cromoglycate in patients aged over 50 years with asthma. Respir Med 1993; 87:517-23.
48. Furukawa CT, Shapiro GG, Bierman CW, Kraemer MJ, Ward DJ, Pierson WE. A double-blind study comparing the effectiveness of cromolyn sodium and sustained-release theophylline in childhood asthma. Pediatrics 1984; 74:453-9.
49. Turner-Warwick M, Batten JC, Brompton Hospital/Medical Research Council participants. Long-term study of disodium cromoglycate in treatment of severe extrinsic or intrinsic bronchial asthma in adults. Br Med J 1972; 4:383-8.
50. Wells A, Drennan C, Holst P, Jones D, Rea H, Thornley P. Comparison of nedocromil sodium at two dosage frequencies with placebo in the management of chronic asthma. Respir Med 1992; 86:311-6.
51. Laube BL, Edwards AM, Dalby RN, Creticos PS, Norman PS. The efficacy of slow versus faster inhalation of cromolyn sodium in protecting against allergen challenge in patients with asthma. J Allergy Clin Immunol 1998; 101:475-83.
52. Engstrom I, Kraepelien S. The corticosteroid sparing effect of disodium cromoglycate in children and adolescents with bronchial asthma. Acta Allergol 1971; 26:90-100.
53. Morrison-Smith J, Pizarro YA. Observations on the safety of disodium cromoglycate in long-term use in children. Clin Allergy 1972; 2:143-51.
54. Boulet LP, Cartier A, Cockroft DW et al. Tolerance to reduction of oral steroid dosage in severely asthmatic patients receiving nedocromil sodium. Respir Med 1990; 84:317-23.
55. Goldin JG, Bateman ED. Does nedocromil sodium have a steroid sparing effect in adult asthmatic patients requiring maintenance oral corticosteroids? Thorax 1988; 43:982-6.
56. Bone MF, Kubik MM, Keaney NP et al. Nedocromil sodium in adults with asthma dependent on inhaled corticosteroids: a double blind placebo controlled study. Thorax 1989; 44:654-9.
57. Foo AL, Lanteri CJ, Burton PR, Sly PD. The effect of nedocromil sodium on histamine responsiveness in clinically stable asthmatic children. J Asthma 1993; 30:381-90.
58. Toogood JH, Jennings B, Lefcoe NM. A clinical trial of combined cromolyn/beclomethasone treatment for chronic asthma. J Allergy Clin Immunol 1981; 67:317-24.
59. Cogswell JJ, Simpkiss MJ. Nebulised sodium cromoglycate in recurrently wheezy preschool children. Arch Dis Child 1985; 60:736-8.
60. Brogden RN, Sorkin EM. Nedocromil sodium: an updated review of its pharmacological properties and therapeutic efficacy in asthma. Drugs 1993; 45:693-715.
61. Shapiro GG, König P. Cromolyn sodium: a review. Pharmacotherapy 1985; 5:156-70.
62. Settipane GA, Klein DE, Boyd GK, Sturham JH, Freye HB, Weltman JK. Adverse reactions to cromolyn. JAMA 1979; 241:811-3.
63. Brown LA, Kaplan RA, Benjamin PA, Hoffman LS, Shearer WT. Immunoglobulin E-mediated anaphylaxis with inhaled cromolyn sodium. J Allergy Clin Immunol 1981; 68:416-20.
64. Howell JBL. Broad classification of asthma and assessment of therapeutic benefit. In: Pepys J, Frankland AN, eds. Disodium Cromoglycate in Allergic Airways Disease. London: Butterworths, 1970:89-95.